Divi's Laboratories Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
104302.61 Cr.
|
P/BV
|
8.17
|
Book Value (Rs.)
|
480.93
|
52 Week High/Low (Rs.)
|
4100/3051
|
FV/ML
|
2/1
|
P/E(X)
|
57.20
|
Bookclosure
|
11/08/2023
|
EPS (Rs.)
|
68.69
|
Div Yield (%)
|
0.76
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 7665.94 | 8799.23 | 6858.34 | 5291.17 | 4803.82 |
Other Operating Revenues | 101.57 | 160.60 | 111.06 | 103.25 | 142.44 |
Total Operating Revenues | 7767.51 | 8959.83 | 6969.40 | 5394.42 | 4946.26 |
| | | | | |
Other Income | 344.66 | 113.87 | 62.56 | 189.63 | 155.63 |
Total Revenue | 8112.17 | 9073.70 | 7031.96 | 5584.05 | 5101.89 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 3008.36 | 3476.56 | 2397.44 | 2198.41 | 2103.89 |
Purchase Of Stock-In Trade | 22.33 | 14.41 | 5.31 | 16.11 | 25.92 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 23.03 | -523.83 | -78.67 | -105.98 | -304.59 |
Employee Benefit Expenses | 975.02 | 946.16 | 825.76 | 621.05 | 542.27 |
Finance Costs | 0.67 | 0.80 | 0.87 | 6.10 | 3.50 |
Depreciation And Amortisation Expenses | 343.18 | 311.51 | 255.59 | 186.24 | 168.90 |
Other Expenses | 1370.95 | 1164.59 | 959.62 | 842.66 | 706.93 |
Total Expenses | 5743.54 | 5390.20 | 4365.92 | 3764.59 | 3246.82 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2368.63 | 3683.50 | 2666.04 | 1819.46 | 1855.07 |
| | | | | |
Profit/Loss Before Tax | 2368.63 | 3683.50 | 2666.04 | 1819.46 | 1855.07 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 439.17 | 644.00 | 616.46 | 392.79 | 475.51 |
Deferred Tax | 106.08 | 79.05 | 65.29 | 50.13 | 26.82 |
Total Tax Expenses | 545.25 | 723.05 | 681.75 | 442.92 | 502.33 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1823.38 | 2960.45 | 1984.29 | 1376.54 | 1352.74 |
| | | | | |
Profit/Loss From Continuing Operations | 1823.38 | 2960.45 | 1984.29 | 1376.54 | 1352.74 |
| | | | | |
Profit/Loss For The Period | 1823.38 | 2960.45 | 1984.29 | 1376.54 | 1352.74 |
Consolidated Profit/Loss After MI And Associates | 1823.38 | 2960.45 | 1984.29 | 1376.54 | 1352.74 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 |
Diluted EPS (Rs.) | 68.69 | 111.52 | 74.75 | 51.85 | 50.96 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 796.41 | 530.94 | 0.00 | 1024.12 | 265.47 |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 54.57 |